Investment：2011 to date

•Founder and Managing Partner.

•Partner at C-Bridge Capital and CASH Capital, leading the group’s healthcare investment.

•Focused on life sciences investments with experience at 3 funds, with investments >20 companies, with 15 as lead investor, with IRR>50%.

•A reputable figure in the life sciences and healthcare investment community in China.

Entrepreneur： 2004-2010

•Founder/CEO, Longmed, Inc. Beijing, China

•Successfully founded, grew, and sold a biotech firm, with a 25 fold increase in valuation over 5 years.

•Built a nationwide distribution network for medical and life science instruments, well-known for introducing the best medical technologies and products into China.

MNC Experience： 2001-2003

•Pfizer NYC, New Product Development.

•Market analysis, product strategies and business development for Pfizer global pipeline and diverse therapeutic areas.

•Focused on new technologies and external collaborations globally.

•Member of Pfizer China Strategy Group, led product launches in emerging markets.

Credentials

•1985-1990: Tsinghua University, Biology, BS

•1991-1996: UPMC, Molecular Biology, PhD

•1998-2001: University of Chicago, MBA

•Chairman, Alumni Association for Tsinghua University Life Sciences and Medicine

•Senior Member, BayHelix

Investment：2008 to date

•General Manager and board member, Beijing-55 Oriental Investment Company.

•VP, CFO, Oriental Scientific Instrument Import & Export (Group) Corp. (OSIC).

•Acting as LP for CASH in IDG, Sequoia Capital, Legend Capital, and CDH, with an investment total of over 5 billion RMB. Extensively experienced in fund set-up, regulation, and government policies.

Entrepreneur：1984 to date

•1983-1994, Financial Manager, CAS Computing Center

•1994-1997, Deputy Director, CAS Software Incubation Center

•1997 to date, Financial Director, VP of Finance, CFO, Oriental Scientific Instrument Import & Export (Group) Corp. (OSIC).

•2010 to date, General Manager, Beijing-55 Oriental Investment Company.

Professional

•CFO for a major State-Owned Enterprise in China, with extensive experience in financial statements, audits and regulations in China.

•Led the investment of multiple funds in China, including venture, PE, mezzanine, and merger-acquisition fund. Performed due diligence, valuations, and financial auditing.

Credentials

•1979-1983, Jiangxi Financial University, BA in Finance and Accounting

•Registered Accountant and Financial Auditor

Entrepreneur in Residence：2015 to date

•CEO, NetVation Limited, Hong Kong, China

•A joint venture between Chinese Academy of Science and Pfizer, focuses on new drug discovery and development in the Asian market. An incubator for biotech start-ups, headquartered in Beijing, with divisions in Hong Kong, Boston and Hangzhou.

•Venture partner for Anlong, with expertise in new drug R&D and discoveries.

Entrepreneur： 2007 - 2015

•Founder/CEO Alputon (HK) Limited in 2007, a leading preclinical CRO firm focused on drug discovery and development.

•Alputon is a renowned CRO firm for medicinal chemistry. Provided services to MNC and domestic drug companies with advanced biotechnology, drug design, HTS, and crystallization, with two pharmaceutical products in clinical pipelines.

MNC Experience： 1994-2006

•Senor Director / Senior Scientist, ArQule Inc.（NASDAQ: ARQL), Boston, USA, 1997 - 2006；A drug discovery company with unique technology in signal pathways for oncology.

•Team leader and director for medicinal chemistry department, delivered several small molecule drug candidates into clinical stages.

Credentials

•1984-1988，Huazhong University of Science and Technology, Chemistry, BS.

•1989-1994，CAS, Organic Chemistry, PhD

•1994-1997，University of Miami, Post-Doc

•1999, Sloan, MIT, Strategy and Finance

•Senior Member, BayHelix